06-07-2022-0719 - 72 people at high-profile D.C. dinner test positive for Covid

James Bond Hollywood Movie Idea Start Conflict Opening Scene



CORONAVIRUS

72 people at high-profile D.C. dinner test positive for Covid
Agriculture Secretary Tom Vilsack, Attorney General Merrick Garland and Commerce Secretary Gina Raimondo were among the guests at the annual Gridiron Dinner.
https://www.nbcnews.com/politics/politics-news/67-attendees-test-positive-covid-high-profile-dc-dinner-rcna23763

COVITTY

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

Share

Tweet

Linkedin

Email

Print

 

For Immediate Release:

December 22, 2021

Español

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset. 

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.” 

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19